Page 5 - Molly Wylenzek News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Molly wylenzek. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Molly Wylenzek Today - Breaking & Trending Today

Nestle Prepares Aids for Wegovy Users as Revenue Growth Ebbs

(Bloomberg) Nestle SA is working on products designed to complement a new class of weight-loss drugs after revenue growth decelerated to the weakest pace in almost three years.Most Read from BloombergRinggit Falls to 25-Year Low, the Worst Performer in Asia After Yen This YearTesla Tempers Growth Expectations as Musk Sees Storm AheadWhere Does Israel Get Its 220,000 Barrels of Oil Every Day?Biden Vows Aid for Gaza, Backs Israel Over Hospital BlastQQQ Advances in Late Trading as Tesla Rebounds ....

Anthony Pettinari , Novo Nordisk , Mark Schneider , Bloomberg Businessweek , Greg Behar , Allegra Catelli , Molly Wylenzek , Walmart Inc , Nestle Health Science , Chief Executive Officer Mark Schneider , Lean Cuisine , Ozempic Threatens Profits , Beverage Makers , Weight Loss , Nestle Health Science , Nestle Sa , Revenue Growth ,

LOREAL : Receives a Sell rating from Jefferies -October 19, 2023 at 03:27 pm EDT

The analyst from Jefferies, Molly Wylenzek, maintains his advice to sell. The target price remains unchanged at EUR 350. ....

Molly Wylenzek ,

NESTLE : Jefferies remains Neutral -October 19, 2023 at 06:19 am EDT

Analyst Molly Wylenzek from Jefferies research gives the stock a Neutral rating. The target price is still set at CHF 115. ....

Molly Wylenzek , Analyst Molly Wylenzek ,

HENKEL VORZUEGE : Jefferies remains Neutral -October 06, 2023 at 07:00 am EDT

In a research note published by Molly Wylenzek, Jefferies gives a Neutral rating to the stock. The target price remains unchanged at EUR 76. ....

Molly Wylenzek ,

BEIERSDORF AG : Jefferies gives a Buy rating -Today at 01:59 am

Analyst Molly Wylenzek from Jefferies research considers the stock attractive and recommends it with a Buy rating. The target price has been raised from EUR 140 to EUR 152. ....

Molly Wylenzek , Analyst Molly Wylenzek ,